etomoxir has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, MP; Cole, J; Goodyear, CS; Kurian, N; McInnes, IB; Rattigan, KM; Rodgers, LC | 1 |
| Bohensky, J; Freeman, T; Shapiro, IM; Srinivas, V; Watanabe, H | 1 |
2 other study(ies) available for etomoxir and Hypoxia
| Article | Year |
|---|---|
The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion.
Topics: Arthritis, Rheumatoid; Carnitine; Cellular Microenvironment; Chemokine CCL20; Chromatography, Liquid; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Gene Expression Profiling; Humans; Hypoxia; In Vitro Techniques; Lipopolysaccharides; Mass Spectrometry; Metabolomics; Microarray Analysis; Monocytes; Synovial Fluid; Synovial Membrane | 2020 |
Hypoxic induction of UCP3 in the growth plate: UCP3 suppresses chondrocyte autophagy.
Topics: Animals; Autophagy; Cattle; Cells, Cultured; Chondrocytes; Cytochromes c; Enzyme Inhibitors; Epoxy Compounds; Gene Expression Regulation; Growth Plate; Hypoxia; Ion Channels; Membrane Potentials; Mice; Mitochondria; Mitochondrial Proteins; RNA, Small Interfering; Staurosporine; Uncoupling Protein 3 | 2008 |